Christopher Sullivan

Direttore Finanziario/CFO presso AVALO THERAPEUTICS, INC.

Patrimonio netto: 75 $ in data 30/06/2024

40 anni

54 relazioni

Health Technology

Commercial Services

Consumer Services

Profilo

Christopher Sullivan is currently the Chief Financial Officer at Avalo Therapeutics, Inc. He previously worked as a Senior Manager at Ernst & Young LLP.
Additionally, he served as a Controller at OpGen, Inc. from 2015 to 2017 and at Sucampo Pharmaceuticals LLC from 2017 to 2018.
Mr. Sullivan completed his undergraduate degree at the University of Maryland.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
AVALO THERAPEUTICS INC 0.00%	17/06/2024	6 ( 0.00% )	75 $	30/06/2024

Posizioni attive di Christopher Sullivan

Società	Posizione	Inizio
AVALO THERAPEUTICS, INC.	Direttore Finanziario/CFO	14/02/2022

Tutte le posizioni attive di Christopher Sullivan

Precedenti posizioni note di Christopher Sullivan

Società	Posizione	Fine
SUCAMPO PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	01/04/2018
OPGEN, INC.	Comptroller/Controller/Auditor	01/08/2017
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Christopher Sullivan

Formazione di Christopher Sullivan

University of Maryland

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Sullivan

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
AVALO THERAPEUTICS, INC.	Health Technology
OPGEN, INC.	Commercial Services

Aziende private	2
Sucampo Pharmaceuticals, Inc. Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD.	Health Technology
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.	Commercial Services